Review
Open access
Jul 2026
Cellular Immunotherapy for Acute Myeloid Leukemia: From Bench to Bedside
Acute myeloid leukemia is a clonal malignant disease that arises from hematopoietic stem cells and is characterized by high genetic heterogeneity. AML has a poor prognosis, with a low 5-year survival rate, and is typically treated with chemotherapy. The management of AML, particularly for cases that are relapsed or r...
Yu Wang, Jiaying Wu, Xiaobing Huang et al.
· Immunotherapy Advances · 0 citations